Table 2. Demographic characteristics of CDC42EP3 expression in ovarian cancer.
| Characteristics | Total(N) | Odds ratio | P value |
|---|---|---|---|
| Stage (Stage III&Stage IV vs. Stage I&Stage II) | 376 | 1.432 (0.624–3.404) |
0.401 |
| Primary therapy outcome (CR&PR vs. PD&SD) | 308 | 1.139 (0.618–2.112) |
0.676 |
| Age (> 60 vs. ≤ 60) | 379 | 0.817 (0.545–1.225) |
0.329 |
| Venous invasion (No vs. Yes) | 105 | 0.754 (0.338–1.658) |
0.484 |
| Lymphatic invasion (No vs. Yes) | 149 | 1.674 (0.839–3.385) |
0.146 |
| Tumor residual (NRD vs. RD) | 335 | 1.391 (0.813–2.400) |
0.230 |
| Tumor status (Tumor free vs. With tumor) | 337 | 1.241 (0.736–2.104) |
0.420 |